Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
The Scientist
Most Recent
A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.
The Asian harlequin ladybird carries a biological weapon to wipe out competing species.
Symbiotic fungi on the roots of bean plants can act as an underground signaling network, transmitting early warnings of impending aphid attacks.
The decline of a population of Arctic foxes isolated on a small Russian island may be due to mercury pollution from their diet of seabirds and seals.
Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.
The Bonobo and the Atheist, The Philadelphia Chromosome, Lone Survivors, and Paleofantasy
Research Associate, Perelman School of Medicine, University of Pennsylvania. Age: 27
University of Vermont neurologist Helene Langevin explains some emerging research attempting to explain the benefits of acupuncture.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
